Connection

Pragya Yadav to Antibodies, Viral

This is a "connection" page, showing publications Pragya Yadav has written about Antibodies, Viral.
Connection Strength

0.377
  1. A qualitative IgG ELISA for detection of SARS-CoV-2-specific antibodies in Syrian hamster serum samples. STAR Protoc. 2021 06 18; 2(2):100573.
    View in: PubMed
    Score: 0.090
  2. Persistence of IgG antibodies in survivors of Crimean Congo hemorrhagic fever virus infection, India. J Infect Public Health. 2019 Jul - Aug; 12(4):598-599.
    View in: PubMed
    Score: 0.078
  3. Crimean-Congo Hemorrhagic Fever in Migrant Worker Returning from Oman to India, 2016. Emerg Infect Dis. 2017 06; 23(6):1005-1008.
    View in: PubMed
    Score: 0.068
  4. Performance assessment of seven SARS-CoV-2 IgG enzyme-linked immunosorbent assays. J Med Virol. 2021 Dec; 93(12):6696-6702.
    View in: PubMed
    Score: 0.023
  5. Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques. Nat Commun. 2021 03 02; 12(1):1386.
    View in: PubMed
    Score: 0.022
  6. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):48-60.
    View in: PubMed
    Score: 0.021
  7. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG. Indian J Med Res. 2020 May; 151(5):444-449.
    View in: PubMed
    Score: 0.021
  8. Growth Kinetics of Kyasanur Forest Disease Virus in Mammalian Cell Lines and Development of Plaque Reduction Neutralization Test. Vector Borne Zoonotic Dis. 2019 08; 19(8):630-636.
    View in: PubMed
    Score: 0.019
  9. Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2. J Travel Med. 2021 Jun 01; 28(4).
    View in: PubMed
    Score: 0.006
  10. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 05; 21(5):637-646.
    View in: PubMed
    Score: 0.005
  11. Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):93-114.
    View in: PubMed
    Score: 0.005
  12. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):82-87.
    View in: PubMed
    Score: 0.005
  13. Acute Encephalitis with Atypical Presentation of Rubella in Family Cluster, India. Emerg Infect Dis. 2018 10; 24(10):1923-1925.
    View in: PubMed
    Score: 0.005
  14. Kyasanur Forest Disease Prevalence in Western Ghats Proven and Confirmed by Recent Outbreak in Maharashtra, India, 2016. Vector Borne Zoonotic Dis. 2018 03; 18(3):164-172.
    View in: PubMed
    Score: 0.004
  15. Retrospective analysis of clinical information in Crimean-Congo haemorrhagic fever patients: 2014-2015, India. Indian J Med Res. 2017 May; 145(5):673-678.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.